70 related articles for article (PubMed ID: 17695473)
1. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
Kiss I; Orsós Z; Gombos K; Bogner B; Csejtei A; Tibold A; Varga Z; Pázsit E; Magda I; Zölyomi A; Ember I
Anticancer Res; 2007; 27(4C):2931-7. PubMed ID: 17695473
[TBL] [Abstract][Full Text] [Related]
2. P450 and human cancer.
Kawajiri K; Fujii-Kuriyama Y
Jpn J Cancer Res; 1991 Dec; 82(12):1325-35. PubMed ID: 1778754
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal Cancer.
Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
[TBL] [Abstract][Full Text] [Related]
4. Association between CYP2E1 polymorphisms and colorectal cancer risk: a systematic review and meta-analysis.
Sharzehan MAK; Sito H; Abdullah N; Alexiou A; Papadakis M; Jamal R; Tan SC
Sci Rep; 2022 Nov; 12(1):20149. PubMed ID: 36418904
[TBL] [Abstract][Full Text] [Related]
5. CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.
Kaur G; Jain AK; Singh S
J Genet; 2017 Mar; 96(1):187-201. PubMed ID: 28360405
[TBL] [Abstract][Full Text] [Related]
6.
Fernandes GM; Russo A; Proença MA; Gazola NF; Rodrigues GH; Biselli-Chicote PM; Silva AE; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2016 Dec; 22(45):9974-9983. PubMed ID: 28018104
[TBL] [Abstract][Full Text] [Related]
7. Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies.
Zhu X; Wang Z; He J; Wang W; Xue W; Wang Y; Zheng L; Zhu ML
Oncotarget; 2016 Aug; 7(32):51365-51374. PubMed ID: 27384991
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses.
Vukovic V; Ianuale C; Leoncini E; Pastorino R; Gualano MR; Amore R; Boccia S
BMC Cancer; 2016 Feb; 16():83. PubMed ID: 26865042
[TBL] [Abstract][Full Text] [Related]
9. Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1.
Rao PS; Midde NM; Miller DD; Chauhan S; Kumar A; Kumar S
Curr Drug Metab; 2015; 16(6):486-503. PubMed ID: 26264202
[TBL] [Abstract][Full Text] [Related]
10. Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.
Sun WX; Chen YH; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Shen XL; He XF; Wu LX; Wei W; Zhang L
Mol Genet Genomics; 2015 Apr; 290(2):709-25. PubMed ID: 25472037
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.
Yang X; Wang Y; Wang G
J Exp Clin Cancer Res; 2014 Sep; 33(1):82. PubMed ID: 25261893
[TBL] [Abstract][Full Text] [Related]
12. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
[TBL] [Abstract][Full Text] [Related]
13. Association between the CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility: a meta-analysis.
Hu J; Liu C; Yin Q; Ying M; Li J; Li L; Zhou CX; Wang Y
Mol Genet Genomics; 2014 Jun; 289(3):271-7. PubMed ID: 24514875
[TBL] [Abstract][Full Text] [Related]
14. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.
Peng H; Xie SK; Huang MJ; Ren DL
Tumour Biol; 2013 Aug; 34(4):2389-95. PubMed ID: 23595220
[TBL] [Abstract][Full Text] [Related]
15. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis.
Jiang O; Zhou R; Wu D; Liu Y; Wu W; Cheng N
Tumour Biol; 2013 Apr; 34(2):1215-24. PubMed ID: 23355335
[TBL] [Abstract][Full Text] [Related]
16. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies.
Wang H; Zhang Z; Han S; Lu Y; Feng F; Yuan J
BMC Cancer; 2012 Nov; 12():528. PubMed ID: 23157985
[TBL] [Abstract][Full Text] [Related]
17. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals.
Cordero K; Espinoza I; Caceres D; Roco A; Miranda C; Squicciarini V; Santander P; Lee K; Saavedra I; Quiñones L
Oncol Lett; 2010 May; 1(3):549-553. PubMed ID: 22966341
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine.
Dong N; Yu J; Wang C; Zheng X; Wang Z; Di L; Song G; Zhu B; Che L; Jia J; Jiang H; Zhou X; Wang X; Ren J
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1197-203. PubMed ID: 22426923
[TBL] [Abstract][Full Text] [Related]
20. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
